1. The efficacy of albumin–globulin ratio to predict prognosis in cancer patients

   • Will S. Roberts
   • William Delladio
   • Hoang Nguyen

   Review Article 08 July 2023 Pages: 1101 - 1111

   

2. Effect of a web-based fertility preservation training program for medical professionals in Japan

   • Masanori Ono
   • Miyuki Harada
   • Nao Suzuki

   Original Article 15 June 2023 Pages: 1112 - 1120

   

3. The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma

   • Satoshi Kano
   • Takayoshi Suzuki
   • Akihiro Homma

   Original Article 08 June 2023 Pages: 1121 - 1128

   

4. Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis

   • Masae Yamazaki
   • Shoichi Sekikawa
   • Takeshi Nomura

   Original Article 07 July 2023 Pages: 1129 - 1138

   

5. Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab

   • Yuta Hoshi
   • Satoshi Shirakura
   • Takeshi Beppu

   Original Article 08 July 2023 Pages: 1139 - 1146

   

6. Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer

   • Bo Wang
   • Meng Zhou
   • Ze-fang Ren

   Original Article 10 July 2023 Pages: 1147 - 1157

   

7. Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy

   • Feilong Guo
   • Xiaosong Xiang
   • Guoli Li

   Original Article 15 June 2023 Pages: 1158 - 1165

   

8. Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients

   • Mitsuhiko Ota
   • Hiroshi Saeki
   • Eiji Oki

   Original Article Open access 27 June 2023 Pages: 1166 - 1175

   

9. Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106)

   • Hiroki Yukami
   • Hisato Kawakami
   • Taroh Satoh

   Original Article 07 July 2023 Pages: 1176 - 1182

   

10. Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer

    • Yoshitaka Saito
    • Yoh Takekuma
    • Mitsuru Sugawara

    Original Article 15 June 2023 Pages: 1183 - 1190

    

11. Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab

    • Tomoyuki Nagaoka
    • Hiroki Osumi
    • Eiji Shinozaki

    Original Article 22 June 2023 Pages: 1191 - 1199

    

12. Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer

    • Keiichiro Miyajima
    • Hirotaka Suzuki
    • Takahiro Kimura

    Original Article 11 July 2023 Pages: 1200 - 1206

    

13. Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer

    • Katsuhiko Nara
    • Ayumi Taguchi
    • Yutaka Osuga

    Original Article Open access 22 June 2023 Pages: 1207 - 1217

    

14. Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy

    • Nayuta Tsushima
    • Satoshi Kano
    • Akihiro Homma

    Original Article 17 June 2023 Pages: 1218 - 1226

    

15. Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study

    • Shingo Sato
    • Hideyuki Tomitori
    • Kyoko Akano

    Original Article 14 June 2023 Pages: 1227 - 1235